Howard Capital Management LLC Sells 69,512 Shares of MetLife, Inc. $MET

Howard Capital Management LLC lowered its position in shares of MetLife, Inc. (NYSE:MET) by 95.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,453 shares of the financial services provider’s stock after selling 69,512 shares during the quarter. Howard Capital Management LLC’s holdings in MetLife were worth $325,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of MET. Cantor Fitzgerald Investment Advisors L.P. raised its position in shares of MetLife by 2.1% in the 3rd quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 175,989 shares of the financial services provider’s stock worth $16,571,000 after acquiring an additional 3,557 shares in the last quarter. V Square Quantitative Management LLC boosted its position in shares of MetLife by 0.5% during the 3rd quarter. V Square Quantitative Management LLC now owns 40,436 shares of the financial services provider’s stock valued at $3,807,000 after purchasing an additional 200 shares in the last quarter. AdvisorNet Financial Inc grew its stake in MetLife by 40.5% during the third quarter. AdvisorNet Financial Inc now owns 2,088 shares of the financial services provider’s stock worth $208,000 after purchasing an additional 602 shares during the period. Nvwm LLC grew its stake in MetLife by 655.3% during the third quarter. Nvwm LLC now owns 287 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 249 shares during the period. Finally, Mather Group LLC. grew its stake in MetLife by 4.1% during the third quarter. Mather Group LLC. now owns 7,319 shares of the financial services provider’s stock worth $689,000 after purchasing an additional 285 shares during the period. 94.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. Argus boosted their price target on MetLife from $93.00 to $109.00 and gave the company a “buy” rating in a research note on Wednesday, September 2nd. Wall Street Zen raised shares of MetLife from a “hold” rating to a “buy” rating in a research report on Sunday, September 27th. Keefe, Bruyette & Woods lifted their price objective on shares of MetLife from $105.00 to $108.00 and gave the company an “outperform” rating in a research note on Tuesday, August 11th. Bank of America dropped their target price on shares of MetLife from $106.00 to $103.00 and set a “buy” rating on the stock in a research report on Wednesday, July 15th. Finally, Piper Sandler raised shares of MetLife from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $99.00 to $110.00 in a research note on Tuesday, September 22nd. Thirteen analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, MetLife has an average rating of “Moderate Buy” and an average target price of $105.19.

More MetLife News

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: JPMorgan raised its price target for MetLife from $108 to $110 and maintained an “overweight” rating. The new target implies approximately 9% upside from the referenced share price, signaling continued confidence in MetLife’s earnings outlook and valuation.
• Positive Sentiment: Dowling & Partners increased its FY2026 EPS forecast to $10.30 from $10.10. The revised estimate is also above the broader consensus forecast of $9.90, suggesting expectations for stronger profitability. MetLife Hits New 52-Week High on Analyst Upgrade
• Positive Sentiment: MetLife reached a new 52-week high following an analyst upgrade. The move reflects sustained investor demand and momentum around the insurer’s earnings performance and analyst outlook. MetLife Hits New 52-Week High on Analyst Upgrade
• Positive Sentiment: Brokerages’ consensus price target is reported at $105.06, providing additional evidence that analysts see potential upside for MET. MetLife Consensus Price Target
• Neutral Sentiment: MetLife Foundation awarded a $1 million grant to Ascendus for its Get Ready program. The initiative supports financial preparedness and may enhance MetLife’s corporate reputation, but it is unlikely to materially affect near-term earnings. Ascendus Expands Get Ready Program
• Neutral Sentiment: Articles about concerts, NFL venues and events at MetLife Stadium concern the stadium’s entertainment operations, not MetLife, Inc.’s insurance and financial-services business, so they are not expected to influence MET materially.

MetLife Price Performance

Shares of NYSE MET opened at $100.73 on Friday. The stock has a market cap of $64.82 billion, a price-to-earnings ratio of 19.30, a PEG ratio of 0.95 and a beta of 0.78. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.20 and a current ratio of 0.20. MetLife, Inc. has a fifty-two week low of $67.33 and a fifty-two week high of $102.43. The firm’s 50-day simple moving average is $96.87 and its 200 day simple moving average is $88.73.

MetLife (NYSE:MET) last issued its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $2.43 EPS for the quarter, topping analysts’ consensus estimates of $2.30 by $0.13. The firm had revenue of $13.52 billion during the quarter, compared to analyst estimates of $19.67 billion. MetLife had a return on equity of 23.39% and a net margin of 4.57%. The company’s revenue for the quarter was up 10.5% on a year-over-year basis. During the same period in the previous year, the company posted $2.02 EPS. As a group, research analysts anticipate that MetLife, Inc. will post 9.93 earnings per share for the current fiscal year.

MetLife Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 8th. Investors of record on Tuesday, November 3rd will be given a dividend of $0.5925 per share. The ex-dividend date of this dividend is Tuesday, November 3rd. This represents a $2.37 annualized dividend and a dividend yield of 2.4%. MetLife’s payout ratio is presently 45.40%.

MetLife announced that its Board of Directors has initiated a stock buyback program on Wednesday, August 5th that authorizes the company to repurchase $3.00 billion in outstanding shares. This buyback authorization authorizes the financial services provider to repurchase up to 4.8% of its shares through open market purchases. Stock buyback programs are often an indication that the company’s board of directors believes its shares are undervalued.

MetLife Profile

MetLife, Inc (NYSE: MET) is a global financial services company that provides insurance, retirement, and employee benefits solutions to individuals, employers, and institutions. Its offerings include life insurance, dental and vision coverage, accident and disability insurance, annuities, retirement savings products, and related financial services.

Through its institutional and workplace businesses, MetLife helps employers provide benefits and retirement programs to their employees. The company also serves individual customers with protection and income products.